Pattern of expression of HER2/neu and p53 in premalignant and malignant lesions of uterine cervix

Abstract Methods: It was a descriptive study conducted in histopathologically diagnosed cervical biopsy specimens of carcinoma cervix and cervical intraepithelial neoplasia received in the Department of Pathology, Government Medical College Thiruvananthapuram from 2015 to 2017. Sample size was 50 and immunohistochemical analysis for HER-2/neu and p53 was performed and graded with histopathology as gold standard and analysed for expression of HER-2/neu and p53 and compared with type, grade and stage of tumour. The association was tested using Chi-square test. Results : Out of 50 cases, 24 (48%) were negative, 16 (32%) with 1+ positivity, 9 (18%) with 2+ positivity and 1 (2%) were showing 3+ HER-2/neu expression and it had correlation with higher clinical stage but a statistical correlation was not es­tablished between grade of SCC and intensity of HER-2/neu staining .Out of 50 cases, 17 (34%) were negative, 15(30%) were hav­ing 1+ positivity p53 expression, 10(20%) were show­ing 2+ positivity and 8 (16%) were showing 3+ positivity. Statistical correlation was es­tablished between grade of SCC and intensity of p53 staining but was not established between p53 expression and stage of tumor. Conclusion: The present study indicates that the intensity of HER-2 expression did not increase progressively as grade of lesion increased but showed correlation with higher clinical stage and higher expression among malignant cases as compared to premalignant lesion . There is no evidence to suggest that the overexpression of p53 may be useful as a prognostic indicator. Keywords: Cervical lesions; cervix; HER-2/neu expression; immunostaining

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-02
DOI
https://doi.org/10.5281/zenodo.13626543
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pattern of expression of HER2/neu and p53 in premalignant and malignant lesions of uterine cervix

Zenodo (CERN European Organization for Nuclear Research)
Cervical Cancer and HPV Research
article

Pattern of expression of HER2/neu and p53 in premalignant and malignant lesions of uterine cervix

article en

Abstract

Abstract Methods: It was a descriptive study conducted in histopathologically diagnosed cervical biopsy specimens of carcinoma cervix and cervical intraepithelial neoplasia received in the Department of Pathology, Government Medical College Thiruvananthapuram from 2015 to 2017. Sample size was 50 and immunohistochemical analysis for HER-2/neu and p53 was performed and graded with histopathology as gold standard and analysed for expression of HER-2/neu and p53 and compared with type, grade and stage of tumour. The association was tested using Chi-square test. Results : Out of 50 cases, 24 (48%) were negative, 16 (32%) with 1+ positivity, 9 (18%) with 2+ positivity and 1 (2%) were showing 3+ HER-2/neu expression and it had correlation with higher clinical stage but a statistical correlation was not es­tablished between grade of SCC and intensity of HER-2/neu staining .Out of 50 cases, 17 (34%) were negative, 15(30%) were hav­ing 1+ positivity p53 expression, 10(20%) were show­ing 2+ positivity and 8 (16%) were showing 3+ positivity. Statistical correlation was es­tablished between grade of SCC and intensity of p53 staining but was not established between p53 expression and stage of tumor. Conclusion: The present study indicates that the intensity of HER-2 expression did not increase progressively as grade of lesion increased but showed correlation with higher clinical stage and higher expression among malignant cases as compared to premalignant lesion . There is no evidence to suggest that the overexpression of p53 may be useful as a prognostic indicator. Keywords: Cervical lesions; cervix; HER-2/neu expression; immunostaining

Zenodo (CERN European Organization for Nuclear Research)
Government of Kerala (IN)
Good health and well-being
Openalex Percentile: Top 49%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pattern of expression of HER2/neu and p53 in premalignant and malignant lesions of uterine cervix · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS